THIRD HARMONIC BIO INC. - COMMON STOCK

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

25 7 2023 05:30:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces First Quarter 2023 Financial Results

11 5 2023 14:00:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

29 3 2023 05:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

15 12 2022 04:00:01 提供 Nasdaq GlobeNewswire

Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference

21 11 2022 13:05:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update

09 11 2022 13:15:00 提供 Nasdaq GlobeNewswire

Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

19 9 2022 13:10:00 提供 Nasdaq GlobeNewswire